At meeting held on 03 October 2015
Krebs Biochemicals & Industries announced the Board of Directors of the Company at its meeting held on 03 October 2015, inter alia, has considered and approved the following items of business:- Allotment of 650,000 equity shares of face value of Rs. 10/- each at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) and 680,000 convertible warrants each of which is convertible into one equity share of face value of Rs. 10/- at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) on preferential basis to Hemalata Ravi, Promoter of the Company.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app